Ecolab Inc. Q3 FY2025 earnings call

• Recognized the strength and resilience of Ecolab's team, delivering consistent double-digit earnings growth despite macro uncertainty.
• Sales growth improved in Q3 with accelerating pricing (up to 3% from 2% last quarter) and 1% volume increase. Double-digit organic growth in growth engines like Pest Elimination, Life Sciences, Global High-Tech, and Ecolab Digital. Core businesses also delivered solid growth.
• Breakthrough innovations driving value for customers, with examples like DishIQ, AquaIQ, ReadyDose in Institutional & Specialty, Pest Intelligence platform in Pest Elimination, 3D TRASAR in Global Water, and cutting-edge drug purification resins in Life Sciences.
• One Ecolab strategy unlocking $65 billion growth opportunity, with early successes in Institutional & Specialty and Food & Beverage.
• Pest Elimination had 6% organic sales growth, with Pest Intelligence rollout going well. Life Sciences sales growth improved to 6%, expecting bioprocessing to still grow double digits in Q4. Global High-Tech had 25% sales growth, with pending Ovivo acquisition to make it a ~$900 million business in 2026. Ecolab Digital had 25% sales growth, with $13 billion growth opportunity.
• Efforts to turn around Basic Industries and Paper, shifting resources to emerging opportunities and focusing on innovation to drive operational savings for customers.

Ecolab's growth engines (Pest Elimination, Life Sciences, Global High-Tech, Ecolab Digital) and core businesses (Institutional & Specialty, rest of Global Water) together represent about 85% of total sales, delivering 4% organic sales growth and mid-teens organic operating income growth. Basic Industries and Paper, representing the remaining 15% of global sales, declined 3% in the quarter.

• Increased 2025 full-year adjusted diluted EPS midpoint to $7.53, range $7.48 to $7.58.
• Expect operating income margin to expand steadily, reaching 18% for full year 2025.
• Aim to achieve 20% OI margin by 2027 and 100-150 basis points annual OI margin expansion to 2030, expecting steady 12%-15% earnings growth in 2026 and beyond.

• Macro uncertainty and shifting global dynamics.
• Market softness in Basic Industries and Paper.
• Potential impact of currency movements.
• Competition in certain segments like Pest business.

Q: Luke McFadden asked about Global High-Tech market share wins, Ovivo acquisition, and growth opportunity in microelectronics post-deal.

A: Christophe Beck discussed High-Tech's growth from data centers and microelectronics, Ovivo's role in ultrapure water for microelectronics, and Global High-Tech expected to be ~$900 million in 2026 with double-digit growth.

Q: Ashish Sabadra asked about Basic Industries and Paper returning to growth in 2026, focusing on shifting resources, innovation, and share gains.

A: Christophe Beck mentioned Basic Industries and Paper are margin businesses, industry consolidation issue, but efforts to shift resources, focus on innovation, and leverage One Ecolab strategy to return to growth.

Q: John McNulty asked about pricing, whether it's getting easier to push through due to value proposition or tougher due to price fatigue.

A: Christophe Beck said pricing is in a good place with high retention, total value delivered stronger than pricing, and 2%-3% value price as sweet spot.

Q: Andrew J. Wittmann asked about Water segment top line impact on margin and Pest customer reference.

A: Christophe Beck said excluding Basic Industries and Paper, Water had 4% top line growth and 15% operating income growth; Pest customer is a new one interested in new technology.

Q: Vincent Andrews asked about One Ecolab progress, focus on top 35 customers and rollout to next tiers.

A: Christophe Beck said One Ecolab launched over a year ago, progressing well with customers receptive, and expanding to top 20 E15 in 2026.

Q: Patrick Cunningham asked about SG&A leverage in Pest and Life Sciences, lap of growth investments.

A: Scott Kirkland said SG&A productivity improved 150 basis points since 2019, expecting 20-30 basis points improvement in 2025, and continuing to invest with 25-50 basis points SG&A leverage going forward.

Q: Manav Patnaik asked about how long it will take for growth engines to move the needle in the mix.

A: Christophe Beck said growth engines are growing double digit, mix will shift towards them, expecting them to become 30%-40% of the company in a few years.

Q: David Begleiter asked about price surcharge realization and continuation of 3% pricing.

A: Christophe Beck said hard to track surcharge exactly, 2%-3% is sweet spot, objective to be close to 3% depending on tariff and China developments.

Q: Christopher Parkinson asked about Life Sciences segment top line, capacity additions, and progress towards 2027 goals.

A: Christophe Beck said Life Sciences top line accelerating, capacity challenge in purification business with plant opening in mid-2026, and margin expected to improve towards mid-teens to 30%.

Q: John Ezekiel Roberts asked about hospitality segment, food traffic, and 3D model.

A: Christophe Beck said food traffic stabilized with 1/3 in 3D model, hospitality business doing well with good margins and growth, Specialty business also doing well.

Q: Jeffrey Zekauskas asked about Water business volume growth and Basic Industries/Paper volume decline.

A: Christophe Beck said all segments had positive growth, Paper within Water had low to mid-single growth but improving.

Q: Matthew DeYoe asked about cross-selling in One Ecolab and its contribution to organic growth.

A: Christophe Beck said One Ecolab is working, contributing over average to growth, with examples like Food & Beverage United showing strong performance.

Q: Michael Harrison asked about Food & Beverage performance, underlying market dynamics, and new business wins.

A: Christophe Beck said Food & Beverage had 4% organic growth, combination of share of wallet and new wins, unification of Hygiene and Water driving value for customers.

Q: Laurence Alexander asked about FX impact and levers if currency moves the other way.

A: Scott Kirkland said underlying performance strong, SG&A comp offsetting FX, and commodity costs growing low to mid-single digits being overcome.

Q: Jason Haas asked about Pest business customer acquisition costs and competition.

A: Christophe Beck said customer acquisition costs easier due to early journey, Pest business leading with technology, and healthy competition.

Q: Josh Spector asked about EPS growth in 2026 and volume expectations.

A: Christophe Beck said similar to 2025, expecting 3%-4% top line, positive volume, 2%-3% price, driving 12%-15% EPS, with upside if end markets improve.

Q: Matt Hettwer asked about Ecolab's position in next-generation cooling technologies like direct-to-chip cooling.

A: Christophe Beck said Ecolab is well-positioned with existing technology in cooling and water, focusing on becoming owner of cooling technology for data centers and circular water solutions for microelectronics, with Ovivo's help in ultrapure water.